Quantcast

Latest Scripps Research Institute Stories

2011-11-15 09:39:50

Scientists at The Scripps Research Institute have determined the atomic structure of a protein that the Lassa fever virus uses to make copies of itself within infected cells. The structural data reveal an unexpected molecular crevice where the viral protein grips the viral genes, making this crevice a target for potential antiviral drugs. Lassa fever virus and other arenaviruses infect hundreds of thousands of people annually and are often deadly. Currently there is no specific therapy or...

2011-10-13 20:49:44

The findings advance AIDS vaccine development Researchers at The Scripps Research Institute have uncovered the surprising details of how a powerful anti-HIV antibody grabs hold of the virus. The findings, published in Science Express on October 13, 2011, highlight a major vulnerability of HIV and suggest a new target for vaccine development. "What's unexpected and unique about this antibody is that it not only attaches to the sugar coating of the virus but also reaches through to grab...

Cause of Flu Fatalities Pinpointed by Researchers
2011-09-17 05:07:50

  While illnesses such as influenza are often little more than an inconvenience, sometimes they can become fatal, and now researchers at the Scripps Research Institute claim to have found out why that can happen. Writing in Friday's edition of the journal Cell, the Scripps scientists discovered the source of the severer immune-system reaction known as a "cytokine storm," which "floods the tiny air sacs of the lungs with fluid and infection-fighting cells, blocking off airways and...

2011-09-05 11:23:24

Research offers hope for better treatments for diabetes patients In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. The finding paves the way for the development of anti-diabetic therapeutics with minimal adverse side effects plaguing currently available drugs such as Avandia (rosiglitazone), scheduled to be removed from...

b1d7afc3ff78799ef38d4bd6b430a1ff
2011-07-11 07:35:00

American and Dutch researchers reported over the weekend that they are now one step closer towards the development of a universal flu vaccine that would be effective against all strains of influenza, according to Telegraph Medical Correspondent Stephen Adams."¨The vaccination, which is being jointly developed by the California-based Scripps Research Institute and Crucell Holland BV, a biopharmaceutical company headquartered in the Netherlands, is the topic of a paper published in the...

2011-07-01 17:04:00

SAN DIEGO, July 1, 2011 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded in further support of the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus (S. aureus or "Staph") infections,...

2011-05-23 11:44:00

Novel Compound Could Become an Alternative to Problematic Narcotic Analgesics JUPITER, Fla., May 23, 2011 /PRNewswire-USNewswire/ -- Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain...

2011-04-19 14:25:00

JUNO BEACH, Fla., April 19, 2011 /PRNewswire/ -- NextEra Energy, Inc. and its subsidiary, Florida Power & Light Co., today joined The Scripps Research Institute, one of America's most respected non-profit research organizations, and its Scripps Florida division to announce a cutting-edge collaboration focused on finding creative solutions for the next generation of clean energy. (Logo: http://photos.prnewswire.com/prnh/20110124/FL34682LOGO ) The innovative multi-year partnership...

2011-04-18 09:56:00

JUPITER, Fla., April 18, 2011 /PRNewswire/ -- Scientists from the Florida campus of The Scripps Research Institute have developed the first of a new class of highly selective compounds that effectively suppresses the severity of multiple sclerosis in animal models. The new compound could provide new and potentially more effective therapeutic approaches to multiple sclerosis and other autoimmune diseases that affect patients worldwide. The study appeared April 17, 2011, in an advance...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related